Plain language summary of the J-TAIL-2 study results: a study of Japanese patients with extensive-stage small cell lung cancer that followed their treatment with atezolizumab plus chemotherapy over time.

Miyauchi E, Nishio M, Ohashi K, Osoegawa A, Kikuchi E, Kimura H, Goto Y, Shimizu J, Yoshioka H, Yoshino I, Misumi T, Katakami N, Oki M, Kijima T, Chikamori K, Nishino K, Arai T, Ieda K, Gemma A

Open source

DOI: 10.1080/14796694.2026.2706981
Published: 2026 Aug
Container: Future oncology (London, England)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/14796694.2026.2706981,
  title = {Plain language summary of the J-TAIL-2 study results: a study of Japanese patients with extensive-stage small cell lung cancer that followed their treatment with atezolizumab plus chemotherapy over time.},
  author = {Miyauchi E and Nishio M and Ohashi K and Osoegawa A and Kikuchi E and Kimura H and Goto Y and Shimizu J and Yoshioka H and Yoshino I and Misumi T and Katakami N and Oki M and Kijima T and Chikamori K and Nishino K and Arai T and Ieda K and Gemma A},
  year = {2026},
  journal = {Future oncology (London, England)},
  doi = {10.1080/14796694.2026.2706981},
  url = {https://doi.org/10.1080/14796694.2026.2706981}
}

RIS

TY  - JOUR
TI  - Plain language summary of the J-TAIL-2 study results: a study of Japanese patients with extensive-stage small cell lung cancer that followed their treatment with atezolizumab plus chemotherapy over time.
AU  - Miyauchi E
AU  - Nishio M
AU  - Ohashi K
AU  - Osoegawa A
AU  - Kikuchi E
AU  - Kimura H
AU  - Goto Y
AU  - Shimizu J
AU  - Yoshioka H
AU  - Yoshino I
AU  - Misumi T
AU  - Katakami N
AU  - Oki M
AU  - Kijima T
AU  - Chikamori K
AU  - Nishino K
AU  - Arai T
AU  - Ieda K
AU  - Gemma A
PY  - 2026
JO  - Future oncology (London, England)
DO  - 10.1080/14796694.2026.2706981
UR  - https://doi.org/10.1080/14796694.2026.2706981
ER  -

APA

E, M., M, N., K, O., A, O., E, K., H, K., Y, G., J, S., H, Y., I, Y., T, M., N, K., M, O., T, K., K, C., K, N., T, A., K, I., & A, G. (2026). Plain language summary of the J-TAIL-2 study results: a study of Japanese patients with extensive-stage small cell lung cancer that followed their treatment with atezolizumab plus chemotherapy over time.. Future oncology (London, England). https://doi.org/10.1080/14796694.2026.2706981

Source records

pubmed · retrieved 2026-11-10T14:40:48.761Z